Who owns KAIROS PHARMA LTD?
- Ticker: KAPA
- CUSIP Number: 48301n104
Tip: Access positions for across all investors
Analyze quarterly positions in Kairos Pharma with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Kairos Pharma stock
Who bought or sold KAIROS PHARMA LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Capital Management | 232k | $130k | 100% | Mar 2026 |
|
| Geode Capital Management | 111k | $62k | 53% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 64k | $36k | 100% | Mar 2026 |
|
| Aptus Capital Advisors | 44k | $25k | 0% | Mar 2026 |
|
| SevenBridge Financial | 44k | $30k | 0% | Mar 2026 |
|
| Two Sigma Investments | 40k | $22k | -58% | Mar 2026 |
|
| State Street Corporation | 24k | $14k | 0% | Mar 2026 |
|
| Hrt Financial | 22k | $12k | 1% | Mar 2026 |
|
| Two Sigma Securities | 16k | $9.1k | 100% | Mar 2026 |
|
| Tower Research Capital | 4.0k | $2.2k | -6% | Mar 2026 |
|
| Citigroup | 10.00 | $6.000000 | 100% | Mar 2026 |
|
Who sold out of Kairos Pharma?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Dec 2025 | 322k | $228k |
| XTX Topco | Dec 2025 | 49k | $34k |
| Virtu Financial | Dec 2025 | 20k | $14k |
| Two Sigma Advisers | Dec 2025 | 15k | $11k |
| Advisor Group Holdings | Dec 2025 | 13k | $9.3k |